𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VEGFR3: A New Target for Antiangiogenesis Therapy?

✍ Scribed by Timothy P. Padera; Rakesh K. Jain

Book ID
116404272
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
89 KB
Volume
15
Category
Article
ISSN
1534-5807

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Selection of high affinity human neutral
Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy
✍ Dan Lu; Xenia Jimenez; Haifan Zhang; Peter Bohlen; Larry Witte; Zhenping Zhu πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 222 KB

## Abstract Compelling evidence suggests that vascular endothelial growth factor (VEGF) and its receptors play an important role in angiogenesis associated with tumor growth and metastasis. VEGF exerts its biologic activities through 2 transmembrane tyrosine kinase receptors: the __fms__‐like tyros